<p>Chesley Taft  Associates LLC 在最近向证券交易委员会（SEC）披露的文件中表示，在第三季度将其在 Zoetis Inc.（NYSE:ZTS - 免费报告）的持股比例降低了 61.4%。该基金在季度内出售了 63,356 股后，持有该公司 39,864 股股票。Chesley Taft  Associates LLC 在 Zoetis 的持股在最近一个季度末价值为 5,833,000 美元。</p>
<ul>
<li>哪只宠物股票在 2024 年应该让你兴奋不已？</li>
</ul>
<p>其他一些机构投资者也对该股票的持仓进行了调整。Savvy Advisors Inc. 在第二季度将其在 Zoetis 的持仓增加了 54.0%。Savvy Advisors Inc. 目前拥有 3,177 股该公司的股票，价值 495,000 美元，此前在上个季度增持了 1,114 股。Sound Income Strategies LLC 在第二季度将其在 Zoetis 的持股增加了 54.3%。Sound Income Strategies LLC 目前拥有 432 股该公司的股票，价值 67,000 美元，此前增持了 152 股。Canoe Financial LP 在第二季度将其在 Zoetis 的持股增加了 859.0%。Canoe Financial LP 目前拥有 13,369 股该公司的股票，价值 2,085,000 美元，此前增持了 11,975 股。Strs Ohio 在第一季度新购入了 Zoetis 的股份，价值约为 22,891,000 美元。最后，Chicago Partners Investment Group LLC 在第二季度将其在 Zoetis 的持仓增加了 67.0%。Chicago Partners Investment Group LLC 目前拥有 4,886 股该公司的股票，价值 750,000 美元，此前增持了 1,961 股。目前，92.80% 的股票由机构投资者和对冲基金持有。</p>
<h2>Zoetis 价格表现</h2>
<p>周四，NYSE ZTS 的股票开盘价为 122.42 美元。该股票的 50 日简单移动平均线为 129.65 美元，200 日简单移动平均线为 145.14 美元。该公司的市值为 539.5 亿美元，市盈率为 20.61，市盈率增长比率为 2.78，贝塔系数为 0.97。Zoetis Inc. 的 52 周低点为 115.25 美元，52 周高点为 177.40 美元。该公司的债务与股本比率为 1.31，速动比率为 2.28，流动比率为 3.64。</p>
<ul>
<li>MarketBeat 周回顾 – 07/31 - 08/04</li>
</ul>
<p>Zoetis（NYSE:ZTS - 获取免费报告）最近在 11 月 4 日星期二公布了季度财报。该公司报告季度每股收益为 1.70 美元，超出市场共识预期的 1.62 美元，超出幅度为 0.08 美元。Zoetis 的净利润率为 28.21%，股本回报率为 57.19%。该公司季度收入为 24 亿美元，而分析师预期为 24.2 亿美元。在去年同期，该公司每股收益为 1.58 美元。该公司的收入同比增长了 0.5%。Zoetis 将其 2025 财年的指导目标设定为 6.300-6.400 每股收益。整体来看，股票研究分析师预测 Zoetis Inc. 本财年将发布 6.07 每股收益。</p>
<h2>Zoetis 增加股息</h2>
<p>该公司最近还宣布了季度股息，将于 3 月 3 日星期二支付。1 月 20 日星期二的登记投资者将获得每股 0.53 美元的股息。除息日期为 1 月 20 日。这代表着每年 2.12 美元的股息，收益率为 1.7%。这比 Zoetis 之前的季度股息 0.50 美元有所增加。Zoetis 的股息支付比率（DPR）为 33.67%。</p>
<h2>分析师设定新目标价</h2>
<ul>
<li>上涨的股息使 Zoetis 成为一个绝对赢家</li>
</ul>
<p>几家券商最近对 ZTS 发布了报告。摩根士丹利在 11 月 10 日的研究报告中将 Zoetis 的目标价从 211.00 美元下调至 175.00 美元，并对该股票给予 “增持” 评级。Stifel Nicolaus 在 11 月 18 日的研究报告中将 Zoetis 的目标价从 140.00 美元下调至 130.00 美元，并对该股票给予 “持有” 评级。摩根大通在 11 月 5 日的研究报告中将 Zoetis 的目标价从 230.00 美元下调至 200.00 美元，并对该公司给予 “增持” 评级。汇丰在 12 月 10 日的报告中对 Zoetis 的股票设定了 140.00 美元的目标价。最后，KeyCorp 在 11 月 20 日的报告中开始覆盖 Zoetis 的股票，并对该公司设定了 “行业权重” 评级。六位研究分析师对该股票给予了买入评级，八位分析师对该公司的股票给予了持有评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “持有”，共识目标价为 161.55 美元。</p>
<p><strong>查看我们最新的 ZTS 研究报告</strong></p>
<h2>Zoetis 公司简介</h2>
<p>（免费报告）</p>
<p>Zoetis Inc. 从事动物健康药物、疫苗和诊断产品及服务的发现、开发、生产和商业化，业务遍及美国及国际市场。该公司主要在不同物种中商业化产品，包括家畜，如牛、猪、家禽、鱼和羊等；以及伴侣动物，包括狗、猫和马。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Zoetis</li>
<li>股息支付比率计算器</li>
<li>在铜业巨头自由港上涨 35% 后，分析师关注更多上涨空间</li>
<li>为什么除息日期对投资者来说重要？</li>
<li>为什么 SpaceX 的 IPO 可能成为 GOOGL 股票的重大催化剂</li>
<li>澳大利亚证券交易所（ASX）是什么</li>
<li>Upwork 能否维持其复苏？看涨和看跌的理由</li>
</ul>
<p><strong>想看看其他对冲基金持有的 ZTS 吗？</strong> 访问 HoldingsChannel.com 获取 Zoetis Inc.（NYSE:ZTS - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UWU3ltYm9sPVpUUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UWU3ltYm9sPVpUUw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Zoetis 吗？</h2>
<p>在你考虑硕腾之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及他们推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而硕腾并不在名单上。</p>
<p>虽然硕腾目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

硕腾

<p>Chesley Taft & Associates LLC 在第三季度减少了对 Zoetis Inc. 的持股比例，降幅为 61.4%。Zoetis 的股票开盘价为 122.42 美元，52 周价格区间为 115.25 美元至 177.40 美元。分析师们对其评级意见不一，普遍目标价为 161.55 美元。Zoetis 报告第三季度每股收益为 1.70 美元，超出预期，并将每股股息提高至 0.53 美元</p>

<p>Chesley Taft &amp; Associates LLC lowered its stake in Zoetis Inc. (NYSE:ZTS - Free Report) by 61.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 39,864 shares of the company's stock after selling 63,356 shares during the quarter. Chesley Taft &amp; Associates LLC's holdings in Zoetis were worth $5,833,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Chesley Taft  Associates LLC 在最近向证券交易委员会（SEC）披露的文件中表示，在第三季度将其在 Zoetis Inc.（NYSE:ZTS - 免费报告）的持股比例降低了 61.4%。该基金在季度内出售了 63,356 股后，持有该公司 39,864 股股票。Chesley Taft  Associates LLC 在 Zoetis 的持股在最近一个季度末价值为 5,833,000 美元。</p>
</div><ul>
<li>Which Pet Stock Should Get Your Tail Wagging in 2024?</li>
</ul>
<div class="lb-trans"><ul>
<li>哪只宠物股票在 2024 年应该让你兴奋不已？</li>
</ul>
</div><p>A number of other institutional investors have also made changes to their positions in the stock. Savvy Advisors Inc. grew its position in Zoetis by 54.0% in the 2nd quarter. Savvy Advisors Inc. now owns 3,177 shares of the company's stock valued at $495,000 after acquiring an additional 1,114 shares in the last quarter. Sound Income Strategies LLC grew its holdings in shares of Zoetis by 54.3% in the second quarter. Sound Income Strategies LLC now owns 432 shares of the company's stock valued at $67,000 after purchasing an additional 152 shares in the last quarter. Canoe Financial LP increased its stake in Zoetis by 859.0% during the 2nd quarter. Canoe Financial LP now owns 13,369 shares of the company's stock worth $2,085,000 after buying an additional 11,975 shares during the period. Strs Ohio acquired a new stake in Zoetis during the 1st quarter worth approximately $22,891,000. Finally, Chicago Partners Investment Group LLC boosted its position in Zoetis by 67.0% in the 2nd quarter. Chicago Partners Investment Group LLC now owns 4,886 shares of the company's stock valued at $750,000 after buying an additional 1,961 shares during the period. 92.80% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他一些机构投资者也对该股票的持仓进行了调整。Savvy Advisors Inc. 在第二季度将其在 Zoetis 的持仓增加了 54.0%。Savvy Advisors Inc. 目前拥有 3,177 股该公司的股票，价值 495,000 美元，此前在上个季度增持了 1,114 股。Sound Income Strategies LLC 在第二季度将其在 Zoetis 的持股增加了 54.3%。Sound Income Strategies LLC 目前拥有 432 股该公司的股票，价值 67,000 美元，此前增持了 152 股。Canoe Financial LP 在第二季度将其在 Zoetis 的持股增加了 859.0%。Canoe Financial LP 目前拥有 13,369 股该公司的股票，价值 2,085,000 美元，此前增持了 11,975 股。Strs Ohio 在第一季度新购入了 Zoetis 的股份，价值约为 22,891,000 美元。最后，Chicago Partners Investment Group LLC 在第二季度将其在 Zoetis 的持仓增加了 67.0%。Chicago Partners Investment Group LLC 目前拥有 4,886 股该公司的股票，价值 750,000 美元，此前增持了 1,961 股。目前，92.80% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Zoetis Price Performance</h2>
<div class="lb-trans"><h2>Zoetis 价格表现</h2>
</div><p>Shares of NYSE ZTS opened at $122.42 on Thursday. The stock's 50-day simple moving average is $129.65 and its 200-day simple moving average is $145.14. The firm has a market capitalization of $53.95 billion, a PE ratio of 20.61, a price-to-earnings-growth ratio of 2.78 and a beta of 0.97. Zoetis Inc. has a fifty-two week low of $115.25 and a fifty-two week high of $177.40. The company has a debt-to-equity ratio of 1.31, a quick ratio of 2.28 and a current ratio of 3.64.</p>
<div class="lb-trans"><p>周四，NYSE ZTS 的股票开盘价为 122.42 美元。该股票的 50 日简单移动平均线为 129.65 美元，200 日简单移动平均线为 145.14 美元。该公司的市值为 539.5 亿美元，市盈率为 20.61，市盈率增长比率为 2.78，贝塔系数为 0.97。Zoetis Inc. 的 52 周低点为 115.25 美元，52 周高点为 177.40 美元。该公司的债务与股本比率为 1.31，速动比率为 2.28，流动比率为 3.64。</p>
</div><ul>
<li>MarketBeat Week in Review – 07/31 - 08/04</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 07/31 - 08/04</li>
</ul>
</div><p>Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, beating the consensus estimate of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The company had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.42 billion. During the same period in the prior year, the firm posted $1.58 earnings per share. The firm's revenue was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities research analysts forecast that Zoetis Inc. will post 6.07 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Zoetis（NYSE:ZTS - 获取免费报告）最近在 11 月 4 日星期二公布了季度财报。该公司报告季度每股收益为 1.70 美元，超出市场共识预期的 1.62 美元，超出幅度为 0.08 美元。Zoetis 的净利润率为 28.21%，股本回报率为 57.19%。该公司季度收入为 24 亿美元，而分析师预期为 24.2 亿美元。在去年同期，该公司每股收益为 1.58 美元。该公司的收入同比增长了 0.5%。Zoetis 将其 2025 财年的指导目标设定为 6.300-6.400 每股收益。整体来看，股票研究分析师预测 Zoetis Inc. 本财年将发布 6.07 每股收益。</p>
</div><h2>Zoetis Increases Dividend</h2>
<div class="lb-trans"><h2>Zoetis 增加股息</h2>
</div><p>The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 3rd. Investors of record on Tuesday, January 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Tuesday, January 20th. This represents a $2.12 annualized dividend and a yield of 1.7%. This is an increase from Zoetis's previous quarterly dividend of $0.50. Zoetis's dividend payout ratio (DPR) is 33.67%.</p>
<div class="lb-trans"><p>该公司最近还宣布了季度股息，将于 3 月 3 日星期二支付。1 月 20 日星期二的登记投资者将获得每股 0.53 美元的股息。除息日期为 1 月 20 日。这代表着每年 2.12 美元的股息，收益率为 1.7%。这比 Zoetis 之前的季度股息 0.50 美元有所增加。Zoetis 的股息支付比率（DPR）为 33.67%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><ul>
<li>Rising Dividend Make Zoetis a Doggone Winner</li>
</ul>
<div class="lb-trans"><ul>
<li>上涨的股息使 Zoetis 成为一个绝对赢家</li>
</ul>
</div><p>Several brokerages have recently issued reports on ZTS. Morgan Stanley reduced their price objective on Zoetis from $211.00 to $175.00 and set an &#34;overweight&#34; rating on the stock in a research note on Monday, November 10th. Stifel Nicolaus reduced their price target on Zoetis from $140.00 to $130.00 and set a &#34;hold&#34; rating on the stock in a research report on Tuesday, November 18th. JPMorgan Chase &amp; Co. lowered their price objective on Zoetis from $230.00 to $200.00 and set an &#34;overweight&#34; rating for the company in a research report on Wednesday, November 5th. HSBC set a $140.00 target price on shares of Zoetis in a report on Wednesday, December 10th. Finally, KeyCorp started coverage on shares of Zoetis in a report on Thursday, November 20th. They set a &#34;sector weight&#34; rating for the company. Six research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of &#34;Hold&#34; and a consensus price target of $161.55.</p>
<div class="lb-trans"><p>几家券商最近对 ZTS 发布了报告。摩根士丹利在 11 月 10 日的研究报告中将 Zoetis 的目标价从 211.00 美元下调至 175.00 美元，并对该股票给予 “增持” 评级。Stifel Nicolaus 在 11 月 18 日的研究报告中将 Zoetis 的目标价从 140.00 美元下调至 130.00 美元，并对该股票给予 “持有” 评级。摩根大通在 11 月 5 日的研究报告中将 Zoetis 的目标价从 230.00 美元下调至 200.00 美元，并对该公司给予 “增持” 评级。汇丰在 12 月 10 日的报告中对 Zoetis 的股票设定了 140.00 美元的目标价。最后，KeyCorp 在 11 月 20 日的报告中开始覆盖 Zoetis 的股票，并对该公司设定了 “行业权重” 评级。六位研究分析师对该股票给予了买入评级，八位分析师对该公司的股票给予了持有评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “持有”，共识目标价为 161.55 美元。</p>
</div><p><strong>View Our Latest Research Report on ZTS</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 ZTS 研究报告</strong></p>
</div><h2>Zoetis Company Profile</h2>
<div class="lb-trans"><h2>Zoetis 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.</p>
<div class="lb-trans"><p>Zoetis Inc. 从事动物健康药物、疫苗和诊断产品及服务的发现、开发、生产和商业化，业务遍及美国及国际市场。该公司主要在不同物种中商业化产品，包括家畜，如牛、猪、家禽、鱼和羊等；以及伴侣动物，包括狗、猫和马。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Zoetis</li>
<li>Dividend Payout Ratio Calculator</li>
<li>Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport</li>
<li>Why is the Ex-Dividend Date Significant to Investors?</li>
<li>Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock</li>
<li>What is the Australian Securities Exchange (ASX)</li>
<li>Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Zoetis</li>
<li>股息支付比率计算器</li>
<li>在铜业巨头自由港上涨 35% 后，分析师关注更多上涨空间</li>
<li>为什么除息日期对投资者来说重要？</li>
<li>为什么 SpaceX 的 IPO 可能成为 GOOGL 股票的重大催化剂</li>
<li>澳大利亚证券交易所（ASX）是什么</li>
<li>Upwork 能否维持其复苏？看涨和看跌的理由</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ZTS?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对冲基金持有的 ZTS 吗？</strong> 访问 HoldingsChannel.com 获取 Zoetis Inc.（NYSE:ZTS - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVpUUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=ZTS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Zoetis Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Zoetis 吗？</h2>
</div><p>Before you consider Zoetis, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑硕腾之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及他们推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而硕腾并不在名单上。</p>
</div><p>While Zoetis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然硕腾目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Chesley Taft & Associates LLC 减持了硕腾公司（Zoetis Inc.）的股票 $ZTS